PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
GMED vs. ALGN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


GMEDALGN
YTD Return52.19%-19.11%
1Y Return77.04%8.09%
3Y Return (Ann)4.65%-31.25%
5Y Return (Ann)8.12%-3.44%
10Y Return (Ann)13.74%15.15%
Sharpe Ratio2.300.25
Sortino Ratio3.640.63
Omega Ratio1.481.07
Calmar Ratio1.610.13
Martin Ratio16.400.45
Ulcer Index4.64%20.89%
Daily Std Dev33.07%38.10%
Max Drawdown-47.91%-92.80%
Current Drawdown-3.52%-69.64%

Fundamentals


GMEDALGN
Market Cap$11.36B$16.36B
EPS$0.62$5.86
PE Ratio134.5537.39
PEG Ratio2.171.32
Total Revenue (TTM)$2.48B$3.96B
Gross Profit (TTM)$1.38B$2.78B
EBITDA (TTM)$366.24M$668.71M

Correlation

-0.50.00.51.00.4

The correlation between GMED and ALGN is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

GMED vs. ALGN - Performance Comparison

In the year-to-date period, GMED achieves a 52.19% return, which is significantly higher than ALGN's -19.11% return. Over the past 10 years, GMED has underperformed ALGN with an annualized return of 13.74%, while ALGN has yielded a comparatively higher 15.15% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%30.00%JuneJulyAugustSeptemberOctoberNovember
26.82%
-18.98%
GMED
ALGN

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

GMED vs. ALGN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and Align Technology, Inc. (ALGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GMED
Sharpe ratio
The chart of Sharpe ratio for GMED, currently valued at 2.30, compared to the broader market-4.00-2.000.002.004.002.30
Sortino ratio
The chart of Sortino ratio for GMED, currently valued at 3.64, compared to the broader market-4.00-2.000.002.004.006.003.64
Omega ratio
The chart of Omega ratio for GMED, currently valued at 1.48, compared to the broader market0.501.001.502.001.48
Calmar ratio
The chart of Calmar ratio for GMED, currently valued at 1.61, compared to the broader market0.002.004.006.001.61
Martin ratio
The chart of Martin ratio for GMED, currently valued at 16.40, compared to the broader market0.0010.0020.0030.0016.40
ALGN
Sharpe ratio
The chart of Sharpe ratio for ALGN, currently valued at 0.24, compared to the broader market-4.00-2.000.002.004.000.25
Sortino ratio
The chart of Sortino ratio for ALGN, currently valued at 0.63, compared to the broader market-4.00-2.000.002.004.006.000.63
Omega ratio
The chart of Omega ratio for ALGN, currently valued at 1.07, compared to the broader market0.501.001.502.001.07
Calmar ratio
The chart of Calmar ratio for ALGN, currently valued at 0.13, compared to the broader market0.002.004.006.000.13
Martin ratio
The chart of Martin ratio for ALGN, currently valued at 0.45, compared to the broader market0.0010.0020.0030.000.45

GMED vs. ALGN - Sharpe Ratio Comparison

The current GMED Sharpe Ratio is 2.30, which is higher than the ALGN Sharpe Ratio of 0.25. The chart below compares the historical Sharpe Ratios of GMED and ALGN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JuneJulyAugustSeptemberOctoberNovember
2.30
0.25
GMED
ALGN

Dividends

GMED vs. ALGN - Dividend Comparison

Neither GMED nor ALGN has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

GMED vs. ALGN - Drawdown Comparison

The maximum GMED drawdown since its inception was -47.91%, smaller than the maximum ALGN drawdown of -92.80%. Use the drawdown chart below to compare losses from any high point for GMED and ALGN. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-3.52%
-69.64%
GMED
ALGN

Volatility

GMED vs. ALGN - Volatility Comparison

Globus Medical, Inc. (GMED) and Align Technology, Inc. (ALGN) have volatilities of 10.63% and 10.81%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%JuneJulyAugustSeptemberOctoberNovember
10.63%
10.81%
GMED
ALGN

Financials

GMED vs. ALGN - Financials Comparison

This section allows you to compare key financial metrics between Globus Medical, Inc. and Align Technology, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items